Matthew G. McDevitt

Filings by Matthew G. McDevitt span 2 companies, the busiest being BioMed Realty Trust Inc and BioMed Realty L P. We count 63 filings; the first trade dates from 3 February 2006 and the latest from 13 August 2014.

Sales make up the whole of the open-market record (33 sales, €3.7M). The rest of the record consists of 12 share grants and 4 option exercises. Since January 2014: no purchases and 3 sales on the market.

On 13 August 2014 came the latest disclosure, an open-market sale for €263k in BioMed Realty Trust Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.